vs
EVERTEC, Inc.（EVTC）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
EVERTEC, Inc.的季度营收约是REPLIGEN CORP的1.2倍（$244.8M vs $197.9M），EVERTEC, Inc.净利率更高（15.1% vs 6.7%，领先8.4%），REPLIGEN CORP同比增速更快（13.6% vs 13.1%），EVERTEC, Inc.自由现金流更多（$63.7M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 9.2%）
EVERTEC Inc.是总部位于波多黎各的领先全品类支付技术与交易处理服务商，主要面向拉丁美洲及加勒比地区的金融机构、零售商户和政府客户，提供商户收单、电子资金转账、数字支付解决方案及业务流程外包服务。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
EVTC vs RGEN — 直观对比
营收规模更大
EVTC
是对方的1.2倍
$197.9M
营收增速更快
RGEN
高出0.5%
13.1%
净利率更高
EVTC
高出8.4%
6.7%
自由现金流更多
EVTC
多$46.1M
$17.6M
两年增速更快
RGEN
近两年复合增速
9.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $244.8M | $197.9M |
| 净利润 | $37.0M | $13.3M |
| 毛利率 | — | 52.5% |
| 营业利润率 | 17.6% | 9.0% |
| 净利率 | 15.1% | 6.7% |
| 营收同比 | 13.1% | 13.6% |
| 净利润同比 | -8.9% | 143.9% |
| 每股收益（稀释后） | $0.57 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EVTCRGEN
| Q4 25 | $244.8M | $197.9M | ||
| Q3 25 | $228.6M | $188.8M | ||
| Q2 25 | $229.6M | $182.4M | ||
| Q1 25 | $228.8M | $169.2M | ||
| Q4 24 | $216.4M | $174.1M | ||
| Q3 24 | $211.8M | $154.9M | ||
| Q2 24 | $212.0M | $154.1M | ||
| Q1 24 | $205.3M | $151.3M |
净利润EVTCRGEN
| Q4 25 | $37.0M | $13.3M | ||
| Q3 25 | $32.9M | $14.9M | ||
| Q2 25 | $40.5M | $14.9M | ||
| Q1 25 | $32.7M | $5.8M | ||
| Q4 24 | $40.7M | $-30.3M | ||
| Q3 24 | $24.7M | $-654.0K | ||
| Q2 24 | $31.9M | $3.3M | ||
| Q1 24 | $16.0M | $2.1M |
毛利率EVTCRGEN
| Q4 25 | — | 52.5% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 50.0% | ||
| Q1 25 | — | 53.6% | ||
| Q4 24 | — | 26.1% | ||
| Q3 24 | — | 50.0% | ||
| Q2 24 | — | 49.8% | ||
| Q1 24 | — | 49.5% |
营业利润率EVTCRGEN
| Q4 25 | 17.6% | 9.0% | ||
| Q3 25 | 16.5% | 8.9% | ||
| Q2 25 | 24.4% | 7.6% | ||
| Q1 25 | 21.6% | 3.9% | ||
| Q4 24 | 22.2% | -17.7% | ||
| Q3 24 | 19.6% | -5.1% | ||
| Q2 24 | 20.5% | 1.0% | ||
| Q1 24 | 16.0% | 1.3% |
净利率EVTCRGEN
| Q4 25 | 15.1% | 6.7% | ||
| Q3 25 | 14.4% | 7.9% | ||
| Q2 25 | 17.6% | 8.2% | ||
| Q1 25 | 14.3% | 3.4% | ||
| Q4 24 | 18.8% | -17.4% | ||
| Q3 24 | 11.7% | -0.4% | ||
| Q2 24 | 15.0% | 2.2% | ||
| Q1 24 | 7.8% | 1.4% |
每股收益（稀释后）EVTCRGEN
| Q4 25 | $0.57 | $0.24 | ||
| Q3 25 | $0.51 | $0.26 | ||
| Q2 25 | $0.62 | $0.26 | ||
| Q1 25 | $0.50 | $0.10 | ||
| Q4 24 | $0.62 | $-0.55 | ||
| Q3 24 | $0.38 | $-0.01 | ||
| Q2 24 | $0.49 | $0.06 | ||
| Q1 24 | $0.24 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $306.0M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $621.6M | $2.1B |
| 总资产 | $2.2B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资EVTCRGEN
| Q4 25 | $306.0M | $767.6M | ||
| Q3 25 | $474.7M | $748.7M | ||
| Q2 25 | $290.6M | $708.9M | ||
| Q1 25 | $265.9M | $697.2M | ||
| Q4 24 | $273.6M | $757.4M | ||
| Q3 24 | $275.4M | $784.0M | ||
| Q2 24 | $257.7M | $809.1M | ||
| Q1 24 | $293.7M | $780.6M |
总债务EVTCRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益EVTCRGEN
| Q4 25 | $621.6M | $2.1B | ||
| Q3 25 | $663.8M | $2.1B | ||
| Q2 25 | $612.3M | $2.1B | ||
| Q1 25 | $542.1M | $2.0B | ||
| Q4 24 | $472.5M | $2.0B | ||
| Q3 24 | $502.6M | $2.0B | ||
| Q2 24 | $483.4M | $2.0B | ||
| Q1 24 | $507.3M | $2.0B |
总资产EVTCRGEN
| Q4 25 | $2.2B | $2.9B | ||
| Q3 25 | $2.1B | $2.9B | ||
| Q2 25 | $2.0B | $2.9B | ||
| Q1 25 | $1.9B | $2.9B | ||
| Q4 24 | $1.9B | $2.8B | ||
| Q3 24 | $1.9B | $2.8B | ||
| Q2 24 | $1.9B | $2.9B | ||
| Q1 24 | $2.0B | $2.8B |
负债/权益比EVTCRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $70.0M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $63.7M | $17.6M |
| 自由现金流率自由现金流/营收 | 26.0% | 8.9% |
| 资本支出强度资本支出/营收 | 2.6% | 4.1% |
| 现金转化率经营现金流/净利润 | 1.89× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $203.7M | $93.9M |
8季度趋势，按日历期对齐
经营现金流EVTCRGEN
| Q4 25 | $70.0M | $25.7M | ||
| Q3 25 | $70.9M | $48.1M | ||
| Q2 25 | $48.5M | $28.6M | ||
| Q1 25 | $37.6M | $15.0M | ||
| Q4 24 | $75.2M | $39.2M | ||
| Q3 24 | $53.6M | $49.3M | ||
| Q2 24 | $90.6M | $42.2M | ||
| Q1 24 | $40.7M | $44.7M |
自由现金流EVTCRGEN
| Q4 25 | $63.7M | $17.6M | ||
| Q3 25 | $65.3M | $43.4M | ||
| Q2 25 | $43.5M | $21.5M | ||
| Q1 25 | $31.2M | $11.4M | ||
| Q4 24 | $70.8M | $33.6M | ||
| Q3 24 | $49.7M | $42.3M | ||
| Q2 24 | $78.8M | $37.4M | ||
| Q1 24 | $35.3M | $36.4M |
自由现金流率EVTCRGEN
| Q4 25 | 26.0% | 8.9% | ||
| Q3 25 | 28.5% | 23.0% | ||
| Q2 25 | 18.9% | 11.8% | ||
| Q1 25 | 13.7% | 6.8% | ||
| Q4 24 | 32.7% | 19.3% | ||
| Q3 24 | 23.5% | 27.3% | ||
| Q2 24 | 37.2% | 24.3% | ||
| Q1 24 | 17.2% | 24.0% |
资本支出强度EVTCRGEN
| Q4 25 | 2.6% | 4.1% | ||
| Q3 25 | 2.5% | 2.5% | ||
| Q2 25 | 2.2% | 3.9% | ||
| Q1 25 | 2.8% | 2.1% | ||
| Q4 24 | 2.0% | 3.2% | ||
| Q3 24 | 1.8% | 4.5% | ||
| Q2 24 | 5.6% | 3.1% | ||
| Q1 24 | 2.6% | 5.5% |
现金转化率EVTCRGEN
| Q4 25 | 1.89× | 1.93× | ||
| Q3 25 | 2.16× | 3.23× | ||
| Q2 25 | 1.20× | 1.92× | ||
| Q1 25 | 1.15× | 2.57× | ||
| Q4 24 | 1.85× | — | ||
| Q3 24 | 2.17× | — | ||
| Q2 24 | 2.84× | 12.70× | ||
| Q1 24 | 2.55× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EVTC
| Latin America Payments And Solutions | $101.5M | 41% |
| Business Solutions | $58.3M | 24% |
| Merchant Acquiring Net | $48.2M | 20% |
| Payment Services Puerto Rico Caribbean | $36.8M | 15% |
| Transferred At Point In Time | $4.0M | 2% |
RGEN
暂无分部数据
